EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR-/- MICE

被引：0
|
作者：
Brendel, D. [1 ]
Beutner, F. [1 ]
Teupser, D. [1 ]
Mueller, M. [1 ]
Baber, R. [1 ]
Jeromin, F. [1 ]
Wilfert, W. [1 ]
Ceglarek, U. [1 ]
Thiery, J. [1 ]
机构：
[1] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70843-6
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
MS342
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [41] Improvements of Atherosclerosis and Hepatic Oxidative Stress are Independent of Exercise Intensity in LDLr-/- Mice
    Teodoro, Bruno Gonzaga
    Natali, Antonio Jose
    Toledo Fernandes, Silvio Anderson
    da Silva, Luciano Acordi
    de Pinho, Ricardo Aurino
    Pinto da Matta, Sergio Luis
    Gouveia Peluzio, Maria do Carmo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (10) : 904 - 911
  • [42] Myeloid interferon-γ receptor deficiency does not affect atherosclerosis in LDLR-/- mice
    Boshuizen, Marieke C. S.
    Neele, Annette E.
    Gijbels, Marion J. J.
    van der Velden, Saskia
    Hoeksema, Marten A.
    Forman, Ruth A.
    Muller, Werner
    Van den Bossche, Jan
    de Winther, Menno P. J.
    ATHEROSCLEROSIS, 2016, 246 : 325 - 333
  • [43] Age-related and atherosclerosis-related erythropathy in ApoE/LDLR-/- mice
    Dybas, Jakub
    Bulat, Katarzyna
    Blat, Aneta
    Mohaissen, Tasnim
    Wajda, Aleksandra
    Mardyla, Mateusz
    Kaczmarska, Magdalena
    Franczyk-Zarow, Magdalena
    Malek, Kamilla
    Chlopicki, Stefan
    Marzec, Katarzyna M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (12):
  • [44] Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr-/- mice
    van Leuven, Sander I.
    Mendez-Fernandez, Yanice V.
    Wilhelm, Ashley J.
    Wade, Nekeithia S.
    Gabriel, Curtis L.
    Kastelein, John J.
    Stroes, Erik S.
    Tak, Paul P.
    Major, Amy S.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 408 - 414
  • [45] The PPARδ agonist GW0742X reduces atherosclerosis in LDLR-/- mice
    Graham, TL
    Mookherjee, C
    Suckling, KE
    Palmer, CNA
    Patel, L
    ATHEROSCLEROSIS, 2005, 181 (01) : 29 - 37
  • [46] Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice
    Rajamoorthi, Ananthi
    Lee, Richard G.
    Baldan, Angel
    ATHEROSCLEROSIS, 2018, 275 : 43 - 49
  • [47] The Citrus Flavonoid Nobiletin Prevents Dyslipidemia, Hepatic Steatosis, and Atherosclerosis in Ldlr-/- Mice
    Mulvihill, Erin E.
    Koppes, Julie B.
    Assini, Julia M.
    Sutherland, Brian G.
    Edwards, Jane Y.
    Sawyez, Cythia G.
    Huff, Murray W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E248 - E248
  • [48] ATORVASTATIN ATTENUATES ATHEROSCLEROSIS IN THE VALVES AND FEMURS FROM HYPERCHOLESTEROLEMIC LDLR-/-MICE AS=OP
    Rajamannan, N. M.
    CARDIOLOGY, 2014, 128 : 247 - 247
  • [49] IL-21R BLOCKADE REDUCES ATHEROSCLEROSIS DEVELOPMENT IN LDLR-/- MICE
    Postel, R. J.
    Smit, V.
    De Mol, J.
    Kleijn, M. N. A. Bernabe
    De Jong, M. J. M.
    Delfos, L.
    Hemme, E.
    Depuydt, M. A. C.
    Bot, I.
    Kuiper, J.
    Foks, A. C.
    ATHEROSCLEROSIS, 2022, 355 : E105 - E106
  • [50] Interleukin-12 deficiency decreases atherosclerosis in LDLR-/-, Rag-/- mice
    Nakajima, C
    Nakajima, Y
    Counselman, J
    Bradshaw, G
    Boisvert, WA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A79 - A79
12345